Lineage Cell Therapeutics, Inc. Quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Lineage Cell Therapeutics, Inc. quarterly Operating Lease, Weighted Average Discount Rate, Percent history and growth rate from Q1 2019 to Q3 2024.
  • Lineage Cell Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending September 30, 2024 was 0.06 pure.
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 0.06 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 0.06 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 0.06 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 0.07 0 0% Dec 31, 2023 10-Q 2024-11-14
Q4 2022 0.06 -0.01 -13% Dec 31, 2022 10-K 2024-03-07
Q2 2022 0.08 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 0.08 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 0.08 0 0% Dec 31, 2021 10-Q 2022-08-11
Q3 2021 0.08 -0.01 -11% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 0.08 -0.01 -11% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 0.08 -0.01 -11% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 0.08 -0.01 -11% Dec 31, 2020 10-K 2022-03-10
Q3 2020 0.09 0 0% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 0.09 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 0.09 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 0.09 Dec 31, 2019 10-K 2021-03-11
Q3 2019 0.09 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 0.09 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 0.09 Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.